Top global drugs based on revenue in Q2 2012

Published by Statista Research Department, Sep 4, 2012
This statistic illustrates the top drugs inthe second quarter of 2012, based on revenue worldwide. In this quarter, the antirheumatic Remicade generated 1.92 billion U.S. dollars of revenues worldwide.

Top global drugs based on revenue in Q2 2012 (in billion U.S. dollars)

Drug name (therapeutic area)Revenue in billion U.S. dollars
Humira (rheuma)* 2.41
Enbrel (rheuma)* 2.18
Seretide (asthma) 2.01
Remicade (rheuma)* 1.92
Herceptin (cancer)* 1.61
Crestor (cardiovascular) 1.59
Lantus (diabetes)* 1.59
Avastin (cancer)* 1.51
Singulair (asthma) 1.41
Plavix (cardiac diseases) 1.41
Showing entries 1 to 10 (10 entries in total)
Created with Highcharts 7.2.2Drug name (therapeutic area)Revenue in billion U.S. dollars2.412.412.182.182.012.011.921.921.611.611.591.591.591.591.511.511.411.411.411.41Humira (rheuma)*Enbrel (rheuma)*Seretide (asthma)Remicade (rheuma)*Herceptin (cancer)*Crestor (cardiovascular)Lantus (diabetes)*Avastin (cancer)*Singulair (asthma)Plavix (cardiac diseases)
00.20.40.60.811.21.41.61.822.22.42.62.8

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

September 2012

Region

Worldwide

Survey time period

Q2 2012

Supplementary notes

* Biotech drugs.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Leading companies trust Statista:
paypal google adobe pg samsung telekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on " Pharmaceutical industry in Scandinavia "

Other statistics that may interest you Pharmaceutical industry in Scandinavia

Pharmaceutical sales

8

Patents and clinical trials

6

Trade

5

Key players

6

Further related statistics

10

Discover Statista

Need help with using Statista for your research? Tutorials and first steps

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in HungaryHealthcare in PolandPharmaceutical industry in the UKPharmaceutical market in ItalyPharmaceutical industry in Europe
Do you have any questions about our business solutions?

We provide you with detailed information about our Professional Account.

Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.